Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
TIGERMED Opens 6.6% Lower as Directors and Controlling Shareholders Placed Under Investigation
Recommend 4 Positive 2 Negative 5 |
||||
|
||||
|
TIGERMED (03347.HK) announced that on May 12 (yesterday), directors and controlling shareholders of the company, Ye Xiaoping and Cao Xiaochun, received a case filing notice from the China Securities Regulatory Commission (CSRC) regarding suspected violations of laws and regulations regarding information disclosure related to their changes in the Company’s shareholding. The company stated that both individuals will actively cooperate with the CSRC’s relevant work and will fulfill their information disclosure obligations in strict accordance with regulatory requirements. The board of directors believes that the group's business operation remains normal, and that the aforementioned investigation will not affect the group’s normal operations. TIGERMED opened 6.58% lower this morning at HKD35.52, with pre-market turnover of 76,700 shares, involving HKD2.7244 million. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
